Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,206,860 papers from all fields of science
Search
Sign In
Create Free Account
CKD 516
Known as:
CKD-516
, CKD516
, Tubulin Polymerization Inhibitor CKD-516
A benzophenone derivative and water soluble valine prodrug of the tubulin binding agent S516, with potential tubulin-inhibiting, vascular-disrupting…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Microtubule Process
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Phase I and pharmacokinetic study of the vascular‐disrupting agent CKD‐516 (NOV120401) in patients with refractory solid tumors
H. Kim
,
J. Kang
,
+15 authors
Joong-Won Park
Pharmacology Research & Perspectives
2020
Corpus ID: 212678248
We report a phase I pharmacological study of an oral formulation of CKD‐516, a vascular‐disrupting agent, in patients with…
Expand
2020
2020
Involvement of ER stress and reactive oxygen species generation in anti-cancer effect of CKD-516 for lung cancer
Soojin Kim
,
K. Jegal
,
+5 authors
K. Kang
Cancer Chemotherapy and Pharmacology
2020
Corpus ID: 212655407
Purpose CKD-516 (Valecobulin), a vascular-disrupting agent, inhibits microtubule elongation. We evaluated the effect of CKD-516…
Expand
2014
2014
Enhanced efficacy of CKD-516 in combination with doxorubicin: pre-clinical evaluation using a hepatocellular carcinoma xenograft model.
Young Il Kim
,
Kyung-Won Kim
,
+7 authors
J. Lee
Anticancer Research
2014
Corpus ID: 23139528
AIM To evaluate the anticancer efficacy of CKD-516, a novel vascular-disrupting agent, alone and in combination with doxorubicin…
Expand
2014
2014
CKD-516 displays vascular disrupting properties and enhances anti-tumor activity in combination with chemotherapy in a murine tumor model
C. Moon
,
Seung Ju Lee
,
+5 authors
Y. Min
Investigational new drugs
2014
Corpus ID: 21947262
SummaryPurpose CKD-516 is a benzophenone analog in which the B ring is modified by replacement with a carbonyl group. The study…
Expand
2013
2013
Early quantification of the therapeutic efficacy of the vascular disrupting agent, CKD-516, using dynamic contrast-enhanced ultrasonography in rabbit VX2 liver tumors
I. Joo
,
J. H. Kim
,
J. Lee
,
Jin Woo Choi
,
J. Han
,
B. Choi
Ultrasonography
2013
Corpus ID: 3913601
Purpose: To evaluate the usefulness of dynamic contrast-enhanced ultrasonography (DCE-US) in the early quantification of…
Expand
2013
2013
Dialyse und ethische Probleme beim sehr alten Patienten
W. Kleophas
,
S. Kuhlmann
,
W. Pommer
Der Nephrologe
2013
Corpus ID: 1141691
ZusammenfassungHintergrundÜber einen Zeitraum von 10 Jahren hat sich die Prävalenz älterer Menschen an der Dialyse verdoppelt…
Expand
2012
2012
Wskaźnik filtracji kłębuszkowej jako marker rokowniczy w ostrych zespołach wieńcowych bez uniesienia odcinka ST
Piotr Desperak
,
P. Gąsior
,
Andrzej Brenk
,
Michał Hawranek
,
M. Gąsior
,
L. Poloński
2012
Corpus ID: 70635009
Przewlekla choroba nerek (CKD) jest bardzo rozpowszechnionym schorzeniem wspolistniejącym z wieloma chorobami ukladu sercowo…
Expand
2011
2011
Stanowisko Zespołu Krajowego Konsultanta Medycznego w dziedzinie Nefrologii dotyczące stosowania ketoanalogów aminokwasów i roztworu aminokwasów w leczeniu niedożywienia i zapobieganiu mu u dorosłych…
S. Czekalski
,
B. Rutkowski
,
Sylwia Małgorzewicz
,
Alicja Dębska-Ślizień w imieniu Zespołu Ekspertów
2011
Corpus ID: 70941115
Zastosowanie diet niskobialkowych lub bardzo niskobialkowych u chorych z przewleklą chorobą nerek (CKD, chronic kidney disease…
Expand
2010
2010
Discovery of a potent tubulin polymerization inhibitor: synthesis and evaluation of water-soluble prodrugs of benzophenone analog.
Jaekwang Lee
,
Suyeal Bae
,
+10 authors
K. Lee
Bioorganic & Medicinal Chemistry Letters
2010
Corpus ID: 42498503
2010
2010
PENGARUH METILPREDNISOLON DOSIS RENDAH TERHADAP KADAR hs-CRP DAN C3 PADA PASIEN PENYAKIT GINJAL KRONIS STADIUM V PASCA HEMODIALISIS
Arieff Nurudhin
2010
Corpus ID: 191294232
Latar belakang Mortalitas pasien penyakit ginjal kronik yang menjalani hemodialisa tinggi, 60 % karena komplikasi kardiovaskuler…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE